Polpharma’s USD210.9 Million Revolving Facility Agreement

Polpharma's USD210.9 Million Revolving Facility Agreement

In UK Norton Rose Fulbright, advised on the matter.Clifford Chance advised Polpharma SA Pharmaceutical Works with a team including Andrzej Stosio (Picture – Finance).Norton Rose Fulbright…

This content is for members only.
Join Now
Already a member? Log in here

Author: Giulia Di Palma

This content is for members only.
Join Now
Already a member? Log in here